日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/07/06 | 4,130 | 4,163 | 4,088 | 4,156 | +36 | +0.9% | 190,300 |
| 2026/07/03 | 4,149 | 4,172 | 4,105 | 4,120 | +36 | +0.9% | 167,400 |
| 2026/07/02 | 4,031 | 4,100 | 3,989 | 4,084 | +99 | +2.5% | 284,400 |
| 2026/07/01 | 3,988 | 4,030 | 3,971 | 3,985 | -31 | -0.8% | 197,400 |
| 2026/06/30 | 4,068 | 4,103 | 4,003 | 4,016 | -89 | -2.2% | 291,900 |
| 2026/06/29 | 4,115 | 4,122 | 4,038 | 4,105 | +56 | +1.4% | 358,800 |
| 2026/06/26 | 3,991 | 4,060 | 3,983 | 4,049 | +12 | +0.3% | 270,500 |
| 2026/06/25 | 4,076 | 4,087 | 4,022 | 4,037 | -10 | -0.2% | 234,000 |
| 2026/06/24 | 3,987 | 4,047 | 3,984 | 4,047 | +31 | +0.8% | 269,900 |
| 2026/06/23 | 3,960 | 4,029 | 3,932 | 4,016 | +41 | +1% | 273,300 |
| 2026/06/22 | 3,998 | 4,005 | 3,945 | 3,975 | +3 | +0.1% | 205,200 |
| 2026/06/19 | 3,965 | 3,992 | 3,954 | 3,972 | -51 | -1.3% | 346,700 |
| 2026/06/18 | 3,955 | 4,023 | 3,939 | 4,023 | +52 | +1.3% | 212,600 |
| 2026/06/17 | 4,000 | 4,021 | 3,955 | 3,971 | -15 | -0.4% | 127,600 |
| 2026/06/16 | 3,950 | 4,004 | 3,947 | 3,986 | -11 | -0.3% | 146,200 |
| 2026/06/15 | 3,955 | 4,009 | 3,945 | 3,997 | +54 | +1.4% | 154,700 |
| 2026/06/12 | 3,993 | 4,004 | 3,923 | 3,943 | -61 | -1.5% | 220,500 |
| 2026/06/11 | 4,030 | 4,043 | 3,984 | 4,004 | -40 | -1% | 163,700 |
| 2026/06/10 | 4,048 | 4,073 | 3,989 | 4,044 | -6 | -0.1% | 162,000 |
| 2026/06/09 | 4,043 | 4,096 | 4,010 | 4,050 | +35 | +0.9% | 194,700 |
| 2026/06/08 | 4,011 | 4,050 | 3,965 | 4,015 | -50 | -1.2% | 194,100 |
| 2026/06/05 | 4,091 | 4,116 | 4,045 | 4,065 | +44 | +1.1% | 111,900 |
| 2026/06/04 | 3,989 | 4,078 | 3,966 | 4,021 | +32 | +0.8% | 178,300 |
| 2026/06/03 | 4,034 | 4,055 | 3,965 | 3,989 | -66 | -1.6% | 204,100 |
| 2026/06/02 | 4,112 | 4,147 | 4,055 | 4,055 | -127 | -3% | 275,900 |
| 2026/06/01 | 4,101 | 4,220 | 4,037 | 4,182 | -19 | -0.5% | 279,000 |
| 2026/05/29 | 4,140 | 4,245 | 4,140 | 4,201 | +111 | +2.7% | 380,000 |
| 2026/05/28 | 4,120 | 4,168 | 4,055 | 4,090 | -60 | -1.4% | 350,100 |
| 2026/05/27 | 4,140 | 4,203 | 4,055 | 4,150 | +31 | +0.8% | 476,900 |
| 2026/05/26 | 4,186 | 4,209 | 4,089 | 4,119 | -92 | -2.2% | 201,500 |
| 2026/05/25 | 4,211 | 4,264 | 4,197 | 4,211 | +2 | ±0% | 196,300 |
| 2026/05/22 | 4,242 | 4,280 | 4,189 | 4,209 | -54 | -1.3% | 193,300 |
| 2026/05/21 | 4,304 | 4,304 | 4,237 | 4,263 | +25 | +0.6% | 115,500 |
| 2026/05/20 | 4,259 | 4,341 | 4,238 | 4,238 | +1 | ±0% | 212,300 |
| 2026/05/19 | 4,273 | 4,305 | 4,203 | 4,237 | +18 | +0.4% | 176,200 |
| 2026/05/18 | 4,299 | 4,368 | 4,194 | 4,219 | -18 | -0.4% | 243,300 |
| 2026/05/15 | 4,143 | 4,361 | 4,140 | 4,237 | +120 | +2.9% | 511,100 |
| 2026/05/14 | 4,176 | 4,200 | 4,102 | 4,117 | -58 | -1.4% | 270,400 |
| 2026/05/13 | 4,167 | 4,219 | 4,157 | 4,175 | +63 | +1.5% | 316,800 |
| 2026/05/12 | 4,068 | 4,167 | 4,049 | 4,112 | +47 | +1.2% | 319,400 |
| 2026/05/11 | 4,001 | 4,083 | 3,913 | 4,065 | -28 | -0.7% | 609,800 |
| 2026/05/08 | 4,314 | 4,315 | 4,093 | 4,093 | -700 | -14.6% | 729,400 |
| 2026/05/07 | 4,800 | 4,848 | 4,739 | 4,793 | +13 | +0.3% | 204,200 |
| 2026/05/01 | 4,768 | 4,780 | 4,659 | 4,780 | -10 | -0.2% | 188,000 |
| 2026/04/30 | 4,887 | 4,910 | 4,762 | 4,790 | -99 | -2% | 191,900 |
| 2026/04/28 | 4,878 | 4,889 | 4,817 | 4,889 | +53 | +1.1% | 132,700 |
| 2026/04/27 | 4,867 | 4,885 | 4,817 | 4,836 | -75 | -1.5% | 184,200 |
| 2026/04/24 | 4,990 | 5,021 | 4,877 | 4,911 | -113 | -2.2% | 215,600 |
| 2026/04/23 | 4,960 | 5,071 | 4,960 | 5,024 | +3 | +0.1% | 175,800 |
| 2026/04/22 | 5,012 | 5,045 | 4,972 | 5,021 | +29 | +0.6% | 170,000 |
1～
50
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 412,900円 | +17.1% | +5.9% | 3.00% | 9.18倍 | 0.95倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 152,550円 | +19.1% | -10.3% | 0.00% | 8.89倍 | 2.34倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ロート | 252,650円 | +7.5% | -3.9% | 1.98% | 16.55倍 | 1.89倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| ツムラ | 378,100円 | +10.9% | -11.3% | 4.18% | 10.75倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 東和薬品 | 408,000円 | +11.1% | +6.8% | 2.08% | 9.34倍 | 1.13倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
